Results 261 to 270 of about 941,442 (284)

Hepatocellular Carcinoma

Clinics in Liver Disease, 2006
The number of patients who have hepatocellular carcinoma (HCC) is expected to more than double over the next 1 to 2 decades. Patients who have cirrhosis, regardless of cause, are at the highest risk for developing HCC. This article discusses surveillance of these patients for HCC by alpha-fetoprotein and ultrasound, evaluation using imaging ...
Jorge A, Marrero, Shawn, Pelletier
openaire   +2 more sources

Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma

Cell, 2021
Giacomo Volpe, Yuanfei Peng, Jia Fan
exaly  

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
Mala K Maini, Andrew X Zhu, Josep M Llovet   +2 more
exaly  

Biomarkers for immunotherapy of hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2023
Xin Wei Wang, Tim F Greten, Benjamin Ruf
exaly  

Hepatocellular carcinoma

Seminars in Surgical Oncology, 1996
openaire   +2 more sources

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

Journal of Hepatology, 2022
Daneng Li, Andrew X Zhu, Peter R Galle
exaly  

Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy

Nature Reviews Clinical Oncology, 2023
Fasiha Kanwal, Amit Singal, Josep M. Llovet   +2 more
exaly  

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma†

Ca-A Cancer Journal for Clinicians, 2012
Anne M Covey
exaly  

Hepatocellular Carcinoma

Disease-a-Month, 2008
Willscott E, Naugler, Jonathan M, Schwartz   +1 more
openaire   +2 more sources

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Cell, 2017
Chris Sander, David Neil Hayes
exaly